Stock analysis, trade plans, and proprietary indicators by Trend Edge.
About Ultragenyx
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatem… Read full Trend Edge analysis →
Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
IPO Date: January 31, 2014
Headquarters: 60 Leveroni Court, Novato, CA, United States, 94949
Founder-Led: Yes — Emil Kakkis (Founder, President and Chief Executive Officer)
Key Metrics
Current Price
$23.39
Market Cap
$2.34B
Float
94.6M
Shares Outstanding
98.5M
Price/Sales (TTM)
3.49
vs. Analyst Target
+119.8% to analyst PT
Profit Margin
-90.90%
Operating Margin (TTM)
-102.21%
Revenue (TTM)
$670M
Dividend Rate
None
Analyst Target Price
$51.42 (20 analysts)
Financial History
Annual Revenue & Earnings History
Year
Revenue
Net Income
Gross Profit
EBITDA
2020
$271M
-$187M
$265M
-$140M
2021
$351M
-$454M
$335M
-$410M
2022
$363M
-$707M
$335M
-$640M
2023
$434M
-$607M
$389M
-$516M
2024
$560M
-$569M
$484M
-$469M
2025
$673M
-$575M
$564M
-$500M
Recent Quarterly Revenue & Net Income
Quarter
Revenue
Net Income
Jun 2025
$166M
-$115M
Sep 2025
$160M
-$180M
Dec 2025
$207M
-$129M
Mar 2026
$136M
-$185M
Ownership & Float
Insider Ownership
3.5%
Institutional Ownership
104.2%
Short Float
14.4%
% of All Funds Holding
3.30%
Number of Funds Holding
271
Current Moving Averages
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$23.67
Near-term / short-term trend
Weekly
40-Week SMA
$27.31
Medium-term trend
Weekly
80-Week SMA
$32.70
Cyclical trend (business cycle)
Weekly
200-Week SMA
$39.72
Secular trend (multi-year)
Monthly
10-Month SMA
$26.89
Near-term monthly trend
Monthly
20-Month SMA
$33.42
Medium-term monthly trend
Monthly
40-Month SMA
$38.84
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Price Level
Type
Volume Ratio
Age
$34.30
resistance
1.92x
4 months ago
$36.20
resistance
2.90x
9 months ago
$39.00
resistance
1.26x
11 months ago
$47.00
resistance
1.00x
16 months ago
Historical Earnings Reactions (50 events)
Timeframe
Avg Return
Median
Win Rate
Best
Worst
Gap
-0.30%
-0.28%
44.00%
6.91%
-10.97%
1 Day
-1.10%
-1.09%
36.00%
14.31%
-13.38%
1 Week
0.63%
-0.87%
44.00%
39.10%
-22.52%
2 Weeks
1.38%
-0.44%
48.00%
37.94%
-26.92%
1 Month
2.40%
1.62%
55.10%
36.90%
-31.43%
Next earnings: July 24, 2026 (56 days away)
Seasonality & Day-of-Week Patterns
Monthly Seasonality
Month
Avg Return
Win Rate
Samples
Jan
1.7%
66.7%
12
Feb
6.5%
53.8%
13
Mar
-6.0%
38.5%
13
Apr
1.8%
38.5%
13
May
2.9%
41.7%
12
Jun
6.5%
75.0%
12
Jul
0.0%
41.7%
12
Aug
3.5%
58.3%
12
Sep
-5.5%
25.0%
12
Oct
-5.6%
25.0%
12
Nov
3.7%
50.0%
12
Dec
1.6%
58.3%
12
Day-of-Week Tendencies
Day
Avg Return
Win Rate
Samples
Monday
-0.16%
49.1%
580
Tuesday
0.12%
50.9%
639
Wednesday
0.30%
52.6%
635
Thursday
-0.19%
46.1%
622
Friday
0.16%
50.2%
620
Top Institutional Holders
Institutional holder breakdown coming soon.
Total institutional ownership: 104.2%
Insider Transactions — Smart Summary
Total insider ownership: 3.5%
Founder-led management: Emil Kakkis (Founder, President and Chief Executive Officer)
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Ultragenyx
(RARE) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.